Cargando…
COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now–New Hopes?
The DisCoVeRy clinical trial aimed at the evaluation of four treatments for patients suffering from severe to critical COVID-19: Hydroxychloroquine, eventually associated with azithromycin; the combination lopinavir/ritonavir; the combination with the addition of interferon β-1a; remdesivir. The tri...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308776/ https://www.ncbi.nlm.nih.gov/pubmed/34358090 http://dx.doi.org/10.3390/ph14070664 |